Symmetry Investments’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,640
Closed -$1.17M 157
2024
Q2
$1.17M Buy
+3,640
New +$1.18M 0.13% 106
2024
Q1
Sell
-1,168
Closed -$316K 217
2023
Q4
$316K Sell
1,168
-6,014
-84% -$1.49M 0.02% 175
2023
Q3
$1.77M Buy
+7,182
New +$1.97M 0.36% 69
2022
Q2
Sell
-35,410
Closed -$8.87M 109
2022
Q1
$8.87M Buy
35,410
+29,410
+490% +$7.39M 1.3% 23
2021
Q4
$1.54M Sell
6,000
-8,000
-57% -$1.96M 0.48% 43
2021
Q3
$3.4M Buy
14,000
+2,539
+22% +$621K 0.52% 57
2021
Q2
$2.37M Buy
11,461
+2,461
+27% +$502K 0.67% 36
2021
Q1
$1.7M Buy
+9,000
New +$1.59M 0.41% 47

Other funds holding HCA

Symmetry Investments's HCA Position: Q3 2024 in Review

Symmetry Investments sold out of HCA Healthcare (HCA) in Q3 2024, closing a stake of 3,640 shares — an estimated $1.17M sold.

Symmetry Investments first reported a position in HCA in Q1 2021 and held it in 8 quarters. The position peaked at $8.87M in Q1 2022. 1,202 funds tracked by Wall St. Rank hold HCA as of Q3 2024.

  • Symmetry Investments reported no remaining HCA Healthcare position as of Q3 2024 after selling out during the quarter.
  • Symmetry Investments sold 3,640 HCA Healthcare shares in Q3 2024, an estimated $1.17M.
  • Symmetry Investments first reported a position in HCA Healthcare in Q1 2021 and held it in 8 quarters.
  • Symmetry Investments's HCA Healthcare position peaked at $8.87M in Q1 2022.
  • 1,202 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2024.

Based on Symmetry Investments's 13F filing for Q3 2024, filed 14 Nov 2024.